3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
70
Lymphoma
54
Lymphoma, Large B-Cell, Diffuse
40
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Hodgkin Disease
26
Sarcoma
25
Lymphoma, Follicular
25
Lymphoma, Non-Hodgkin
24
Leukemia
19
Burkitt Lymphoma
17
Multiple Myeloma
16
Endometrial Neoplasms
15
Neuroblastoma
14
Ovarian Neoplasms
12
Carcinoma, Hepatocellular
12
Lymphoma, Large-Cell, Immunoblastic
11
Lymphoma, Mantle-Cell
10
Liposarcoma
9
Neoplasms
8
Lymphoma, Large-Cell, Anaplastic
8
Leiomyosarcoma
8
Histiocytoma, Malignant Fibrous
8
Urinary Bladder Neoplasms
7
Lymphoma, B-Cell, Marginal Zone
7
Hemangiosarcoma
7
Fibrosarcoma
7
Wilms Tumor
6
Triple Negative Breast Neoplasms
6
Sarcoma, Synovial
6
Neurofibrosarcoma
6
Interventions
Diathermy
3
Drug Therapy
2
Radiotherapy
1
Radiation
1
Mitomycin
1
Gemcitabine
1
Fluorouracil
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Conization
1
Cisplatin
1
Capecitabine
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Hyperthermia
×
Doxorubicin
×
Clear all
NCT01204801
2015-09-24
Medifocus301
Medifocus, Inc.
Phase 3
Unknown
238 enrolled